US pharmaceutical company Moderna will bill countries wanting to buy a vaccine candidate against COVID-19 between $ 25 and $ 37 per dose, Moderna CEO Stephane Bancel told German newspaper Welt am Sonntag on Sunday, adding that the company was close to reaching a deal. . with the EU on vaccine supply.
According to the CEO, that is a reasonable price, considering how much it costs the health care system to treat seriously ill COVID-19 patients. The price per dose will vary depending on the volume of supplies.
Bancel also said that the company is expected to produce 20 million doses of vaccine by the end of the year, with a “fraction” available in Europe this year, as Moderna will agree to the matter with the European Commission. The CEO is confident that an agreement on vaccine supply will be reached in a few days.
On Monday, Moderna announced that the mRNA-based vaccine candidate against COVID-19 had proven to be 94.5 percent effective in phase 3 clinical trials.
to request modification Contact us at Here or [email protected]